170 related articles for article (PubMed ID: 32278634)
1. Dopamine, a key factor of mitochondrial damage and neuronal toxicity on rotenone exposure and also parkinsonic motor dysfunction-Impact of asiaticoside with a probable vesicular involvement.
Margabandhu G; Vanisree AJ
J Chem Neuroanat; 2020 Jul; 106():101788. PubMed ID: 32278634
[TBL] [Abstract][Full Text] [Related]
2. Asiaticoside: Attenuation of rotenone induced oxidative burden in a rat model of hemiparkinsonism by maintaining the phosphoinositide-mediated synaptic integrity.
Gopi M; Arambakkam Janardhanam V
Pharmacol Biochem Behav; 2017 Apr; 155():1-15. PubMed ID: 28238857
[TBL] [Abstract][Full Text] [Related]
3. Asiaticoside: attenuation of neurotoxicity induced by MPTP in a rat model of Parkinsonism via maintaining redox balance and up-regulating the ratio of Bcl-2/Bax.
Xu CL; Wang QZ; Sun LM; Li XM; Deng JM; Li LF; Zhang J; Xu R; Ma SP
Pharmacol Biochem Behav; 2012 Jan; 100(3):413-8. PubMed ID: 22001429
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats.
Teerapattarakan N; Benya-Aphikul H; Tansawat R; Wanakhachornkrai O; Tantisira MH; Rodsiri R
Phytomedicine; 2018 May; 44():65-73. PubMed ID: 29895494
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
Abdin AA; Hamouda HE
Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
Xu CL; Qu R; Zhang J; Li LF; Ma SP
Fitoterapia; 2013 Oct; 90():112-8. PubMed ID: 23876367
[TBL] [Abstract][Full Text] [Related]
7. Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells.
Alabi AO; Ajayi AM; Ben-Azu B; Omorobge O; Umukoro S
Metab Brain Dis; 2019 Dec; 34(6):1723-1736. PubMed ID: 31463866
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
[TBL] [Abstract][Full Text] [Related]
9. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
[TBL] [Abstract][Full Text] [Related]
10. Sitagliptin and Liraglutide Modulate L-dopa Effect and Attenuate Dyskinetic Movements in Rotenone-Lesioned Rats.
Badawi GA; Abd El Fattah MA; Zaki HF; El Sayed MI
Neurotox Res; 2019 Apr; 35(3):635-653. PubMed ID: 30673988
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
Farombi EO; Awogbindin IO; Farombi TH; Oladele JO; Izomoh ER; Aladelokun OB; Ezekiel IO; Adebambo OI; Abah VO
Neurotoxicology; 2019 Jul; 73():132-141. PubMed ID: 30930291
[TBL] [Abstract][Full Text] [Related]
12. Phenothiazine normalizes the NADH/NAD
Tapias V; McCoy JL; Greenamyre JT
Redox Biol; 2019 Jun; 24():101164. PubMed ID: 30925294
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.
Javed H; Azimullah S; Abul Khair SB; Ojha S; Haque ME
BMC Neurosci; 2016 Aug; 17(1):58. PubMed ID: 27549180
[TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson's disease.
Lakkappa N; Krishnamurthy PT; M D P; Hammock BD; Hwang SH
Neurotoxicology; 2019 Jan; 70():135-145. PubMed ID: 30472438
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic insights into the protective effect of paracetamol against rotenone-induced Parkinson's disease in rats: Possible role of endocannabinoid system modulation.
Labib AY; Ammar RM; El-Naga RN; El-Bahy AAZ; Tadros MG; Michel HE
Int Immunopharmacol; 2021 May; 94():107431. PubMed ID: 33578261
[TBL] [Abstract][Full Text] [Related]
17. Mic60/mitofilin overexpression alters mitochondrial dynamics and attenuates vulnerability of dopaminergic cells to dopamine and rotenone.
Van Laar VS; Berman SB; Hastings TG
Neurobiol Dis; 2016 Jul; 91():247-61. PubMed ID: 27001148
[TBL] [Abstract][Full Text] [Related]
18. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
[TBL] [Abstract][Full Text] [Related]
19. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
[TBL] [Abstract][Full Text] [Related]
20. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
